Pactiv Evergreen Q2 2024 Adj. EPS $0.17 Misses $0.25 Estimate, Sales $1.338B Miss $1.362B Estimate
Portfolio Pulse from Benzinga Newsdesk
Pactiv Evergreen (NASDAQ:PTVE) reported Q2 2024 adjusted EPS of $0.17, missing the analyst estimate of $0.25 by 32%. Sales were $1.338 billion, also missing the estimate of $1.362 billion by 1.75%. This represents a 6.17% decrease from the same period last year.
July 31, 2024 | 9:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Pactiv Evergreen reported Q2 2024 adjusted EPS of $0.17, missing the analyst estimate of $0.25 by 32%. Sales were $1.338 billion, also missing the estimate of $1.362 billion by 1.75%. This represents a 6.17% decrease from the same period last year.
The significant miss on both EPS and sales estimates, along with a year-over-year sales decline, is likely to negatively impact PTVE's stock price in the short term. Investors may react to the lower-than-expected financial performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100